About this scholarly article
Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial by Zakrzewska, Joanna M; Palmer, Joanne; Morisset, Valerie; Giblin, Gerard MP; Obermann, Mark; Ettlin, Dominik A; Cruccu, Giorgio; Bendtsen, Lars; Estacion, Mark; Derjean, Dominique; Waxman, Stephen G; Layton, Gary; Gunn, Kevin; Tate, Simon is a scholarly article available to read on EtoBox.
- Author
- Zakrzewska, Joanna M; Palmer, Joanne; Morisset, Valerie; Giblin, Gerard MP; Obermann, Mark; Ettlin, Dominik A; Cruccu, Giorgio; Bendtsen, Lars; Estacion, Mark; Derjean, Dominique; Waxman, Stephen G; Layton, Gary; Gunn, Kevin; Tate, Simon
- Publisher
- The Lancet; Elsevier ; The Lancet Publishing Group; Elsevier BV (ISSN 1474-4465)
- Published
- 2017
- Language
- EN